From Medscape Oncology

Medscape Medical News from the

American Society of Clinical Oncology (ASCO) 2015 Annual Meeting

May 29 - June 02, 2015; Chicago, Illinois

MEETING HIGHLIGHTS AT A GLANCE

Top News From ASCO 2015: Slideshow Highlights include practice-changing research in lung, breast, and prostate cancer, plus an eye-opening discussion of cancer drug costs.

Featured

Whole-Brain Radiotherapy: Risks Worth Benefit? Whole-brain radiotherapy should be avoided in patients with brain metastases because it does not prolong survival, it reduces quality of life, and it causes cognitive decline.
Medscape Medical News, June 1, 2015

New Immunotherapy Costing $1 Million a Year The new data being presented at the ASCO meeting are showing remarkable promise with immunotherapies, but these drugs cost too much.
Medscape Medical News, June 1, 2015

Conference News

ASCO First Success With CAR T-Cells in a Solid Tumor
Medscape Medical News, June 18, 2015
ASCO Immunotherapy: Backbone of Future Lung Cancer Treatment?
Medscape Medical News, June 18, 2015
ASCO WHO Adds 16 New Cancer Drugs to Essential Medicines List
Medscape Medical News, June 16, 2015
ASCO Improved Survival in Sarcoma for First Time With Eribulin
Medscape Medical News, June 11, 2015
ASCO Statins and Lower Cancer Mortality; Risk Cut by Up to a Half
Medscape Medical News, June 10, 2015
ASCO ESMO Unveils Scale for Assessing Value of Cancer Drugs
Medscape Medical News, June 10, 2015
ASCO For Some Oncologists Who Choose Un-Wisely: 'Trouble'
Medscape Medical News, June 9, 2015
ASCO Leukemia Drug Is 'Blessing From God,' But Trial Imperfect
Medscape Medical News, June 5, 2015
ASCO Obinutuzumab Doubles PFS in Refractory Non-Hodgkin Lymphoma
Medscape Medical News, June 5, 2015
ASCO Cost Changes Conclusion From Major CRC Trial
Medscape Medical News, June 4, 2015
ASCO Decreased Toxicity Lowers 'Cost of Cure' in Pediatric Cancer
Medscape Medical News, June 4, 2015
ASCO Adding Docetaxel to Induction Improves Larynx Preservation
Reuters Health Information, June 3, 2015
ASCO Shaving Margins After Breast Cancer Surgery Cuts Risk
Medscape Medical News, June 2, 2015
ASCO Unprecedented Responses With Daratumumab in Multiple Myeloma
Medscape Medical News, June 2, 2015
ASCO Palbociclib New Tool Against Endocrine Resistance?
Medscape Medical News, June 1, 2015
ASCO Paradigm-Changing Triplet Therapy for Mesothelioma
Medscape Medical News, June 1, 2015
ASCO Whole-Brain Radiotherapy: Risks Worth Benefit?
Medscape Medical News, June 1, 2015
ASCO New Immunotherapy Costing $1 Million a Year
Medscape Medical News, June 1, 2015

ASCO Potential Practice Change in Management of DCIS
Medscape Medical News, June 1, 2015
ASCO Elective Neck Dissection: New Standard of Care?
Medscape Medical News, May 31, 2015
ASCO Upfront Chemo: New Caution or Option in Prostate Cancer?
Medscape Medical News, May 31, 2015
ASCO Another Sea Change in Melanoma: Immune Combo Triumphs
Medscape Medical News, May 31, 2015
Alert ASCO Sunday at ASCO: News That Will Affect Clinical Practice
News Alerts, May 31, 2015
ASCO New Myelofibrosis Drug Works Even With Thrombocytopenia
Medscape Medical News, May 30, 2015
ASCO Full-Node Dissection Does Not Improve Survival in Melanoma
Medscape Medical News, May 30, 2015
Alert ASCO Saturday at ASCO: Changes for Prostate Cancer & Melanoma
News Alerts, May 30, 2015
ASCO Nivolumab in Lung Cancer Shows Unprecedented Survival
Medscape Medical News, May 29, 2015
ASCO Genomic Marker Predicts Response to Anti-PD-1 Antibody
Medscape Medical News, May 29, 2015
ASCO Add Liver Cancer to Nivolumab's List of Victims
Medscape Medical News, May 29, 2015
ASCO PD-1 Drug Doubles Responses in Head and Neck Cancer
Medscape Medical News, May 29, 2015
ASCO What's Hot at ASCO 2015?
Medscape Medical News, May 21, 2015
ASCO Elotuzumab Offers New Immune Approach to Multiple Myeloma
Medscape Medical News, May 15, 2015
ASCO Chemo Boost Reduces Relapse in High-Risk Wilms' Tumor
Medscape Medical News, May 14, 2015
ASCO Chemo Upfront Ups Survival in Advanced Prostate Cancer
Medscape Medical News, May 13, 2015
ASCO Vitamin B Derivative Reduces Risk for Further Skin Cancer
Medscape Medical News, May 13, 2015

News at a Glance

Cancer Institute Spearheads Largest Precision Medicine Trial The national initiative, part of President Obama's plan to find treatments for cancers that have not responded to traditional therapies, will start enrolling thousands of patients next month.
Medscape Medical News, June 2, 2015
Recognizing the Silent Despair of Burnout in Oncology Healthcare providers learned about one of the most commonly reported problems in the field, and strategies to maintain purpose through it all, at the American Society of Clinical Oncology meeting.
Medscape Medical News, June 1, 2015
Number of Childhood Cancer Survivors on the Rise A federal study of more than 34,000 children with cancer shows that scaled-back treatments have extended the life of many pediatric cancer survivors.
Medscape Medical News, June 1, 2015
Advances in Immune Checkpoint Blockade Headlining Plenary The spotlight will be on the American Society of Clinical Oncology meeting's biggest stage this afternoon as investigators from around the world present cutting-edge findings.
Medscape Medical News, May 31, 2015
Preventive Surgery Saves Lives in Early Oral Cancer Researchers now say preventive neck lymph node surgery is best in early oral cancer, resolving an issue 50 years in the making.
Medscape Medical News, May 31, 2015

Genomic Marker Predicts Immunotherapy Response Researchers are bridging immunotherapy and genomics to help identify which patients will benefit from treatment. It is anticipated that this will have implications for a broad range of cancers.
Medscape Medical News, May 30, 2015
Adding Chemo Boosts Prostate Cancer Survival A federally funded phase 3 clinical trial provides more evidence supporting the addition of docetaxel chemotherapy to standard hormone and radiation treatment in men with high-risk disease.
Medscape Medical News, May 30, 2015
Nivolumab Extends Lung Cancer Survival Results from the long-awaited phase 3 study show that programmed death immunotherapy is an effective treatment for patients with nonsquamous non-small cell lung cancer.
Medscape Medical News, May 29, 2015
The Big Four at ASCO Friday Highly anticipated nivolumab and pembrolizumab results will be among the four clinical trials released opening day of the American Society of Clinical Oncology (ASCO) meeting in Chicago.
Medscape Medical News, May 28, 2015